Viatris Inc. (VTRS) CEO Mike Goettler Presents at 2022 Barclays Global Healthcare Conference (Transcript)Seeking Alpha • 03/16/22
Viatris Inc. Announces Receipt of the First FDA Approval for Generic Version of Symbicort® Inhalation Aerosol, Breyna™ (Budesonide and Formoterol Fumarate Dihydrate Inhalation Aerosol), in Partnership with KindevaPRNewsWire • 03/16/22
Viatris Inc. (VTRS) CEO Michael Goettler Presents at Raymond James 43rd Annual Institutional Investors Conference (Transcript)Seeking Alpha • 03/09/22
Viatris, Inc. (VTRS) CEO Michael Goettler on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/28/22
Viatris stock slides 24% as analysts say sale of biosimilars to Indian partner removes key growth driverMarket Watch • 02/28/22
My Investment Thesis On Viatris Remains Intact After The Sale Of The Biosimilars AssetsSeeking Alpha • 02/28/22